chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Amnesia/ Drove down the wrong side of a 4 lane highway during this time; Full 3rd dose (Not immunocompromised)/ But believes that he received a full dose for the 3rd dose of the vaccin; This spontaneous case was reported by a consumer and describes the occurrence of AMNESIA (Amnesia/ Drove down the wrong side of a 4 lane highway during this time) and ACCIDENTAL OVERDOSE (Full 3rd dose (Not immunocompromised)/ But believes that he received a full dose for the 3rd dose of the vaccin) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 040C21A, 010M20A and 012L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Sep-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 10-Sep-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced ACCIDENTAL OVERDOSE (Full 3rd dose (Not immunocompromised)/ But believes that he received a full dose for the 3rd dose of the vaccin). On 13-Sep-2021, the patient experienced AMNESIA (Amnesia/ Drove down the wrong side of a 4 lane highway during this time). On 10-Sep-2021, ACCIDENTAL OVERDOSE (Full 3rd dose (Not immunocompromised)/ But believes that he received a full dose for the 3rd dose of the vaccin) had resolved. On 13-Sep-2021, AMNESIA (Amnesia/ Drove down the wrong side of a 4 lane highway during this time) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-Sep-2021, Magnetic resonance imaging: normal (normal) could not find anything. On 13-Sep-2021, Scan brain: normal (normal) could not find anything.         No concomitant medications were provided. Patient stated that he was never given any medications or treatments for his symptoms.  Patient stated that he was not immunocompromised, he was a bus driver and drove down the wrong side of a 4 lane highway but  did not lost consciousness. On 13-Sep-2021 patient went to ER for testing of stroke and could not find anything. On 25-Oct-2021 patient went to a neurologist.  Patient also stated that symptoms did not occurred again since the one episode and was planned to return to work in several weeks.   This case was linked to MOD-2022-473269, MOD-2022-473284 (Patient Link).
p/vax pt fever & screaming started; fever never got over 101; painful cry lasted one wk; tylenol & motrin helped until dose wore off; mom said pt had same react w/1st DTAP; being a new mom thought it was nl;
Developed a swollen lymph node under right arm.; itchy throat; Started with itchy nose; cough; nausea; headache; Temp 99.5.; heavy chest; hard breathing; Body aches occurred overnight; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL22613), via an unspecified route of administration in the right arm on 18Mar2021 at 10:45 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism, depression/anxiety, and heart burn. Concomitant medications received within 2 weeks of vaccination included levothyroxine (MANUFACTURE UNKNOWN), fluoxetine (MANUFACTURE UNKNOWN), norgestimate and ethinyl estradiol (TRI-LO SPRINTEC) and omeprazole (OMEPRA), all for unknown indications from unknown date. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9263), via an unspecified route of administration in the right arm on 25Feb2021 at 12:00 as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 18Mar2021 at 16:00, the patient experienced itchy nose and throat that developed into cough, nausea, and headache. Temp 99.5 and developed into heavy chest and hard breathing. Body aches occurred overnight and into the morning of 19Mar2021. Coughing, nausea, and body aches continued, and developed a swollen lymph node under right arm. The patient did not receive treatment for the reported adverse events. The clinical outcome of itchy nose, itchy throat, headache, temperature 99.5, heavy chest, hard breathing, swollen lymph node under right arm were recovering, and body aches, nausea, cough was not recovered.  No follow up attempts are needed. No further information is expected.
Low-grade fever (99.2°F), fatigue, mild headache, body aches, general malaise and soreness at injection site.
Pt. complains of light headed, dizzy, nausea and vomiting x1.
I know afew people who got the shot n later got shingles/Suspected vaccination failure; I know afew people who got the shot n later got shingles; This case was reported by a consumer via media and described the occurrence of suspected vaccination failure in an unspecified number of patients who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional details were provided as follows:  The age at vaccination was not reported.  The patients received Shingles vaccine and later got shingles. This case was considered as suspected vaccination failure, as details regarding completion of primary vaccination schedule, laboratory test confirmation for shingles infection and time to event onset was unknown. The reporter reported that dam if you do and dam if you dont. This case has been linked with US2021AMR128540, reported by same reporter.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR128540:Same reporter.
Patient received Janssen lot#1805020 with expiration of 05/25/2021 at 1420 sitting in upright chair. Vaccinator was notified that he has a history of vasovagal response with needles. This response presents itself as sweating (and possible fainting) and is alleviated by lying down. Client mentioned that previous nurse advised him to smell an alcohol pad to distract and prevent a vasovagal response, as this had worked previously on a glucose check. No medications were disclosed or history of anaphylaxis reported. With this background information, RN offered to have vaccine administered in reclined position, however client refused. RN conferred with co-lead about administration recommendations. Vaccinator then checked in with patient at 1423 to see if patient was okay and patient did not answer the question. RN then felt the client's hand and noticed hand was clammy. At 1425 the reclining chair was brought to the station and patient was transferred into chair, appearing diaphoretic. RN palpated pulse and noted patient was not tachycardia, but RN did note tachypnea and uneasiness. RN then provided distraction and promoted relaxation. Then at 1426 patient reported feeling okay and RN noted patient no longer felt clammy. At 1440 patient was asked if he would prefer if EMS should be called, patient declined and stated that he was able to drive home. Then at 1447 patient left the site appearing well, alert and oriented x3 leaving by self in private car.
elevated ALT/ALT increased more; This spontaneous case was reported by a consumer and describes the occurrence of ALANINE AMINOTRANSFERASE INCREASED (elevated ALT/ALT increased more) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced ALANINE AMINOTRANSFERASE INCREASED (elevated ALT/ALT increased more). At the time of the report, ALANINE AMINOTRANSFERASE INCREASED (elevated ALT/ALT increased more) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-Jan-2021, Alanine aminotransferase: elevated (High) elevated. On 28-Jan-2021, Alanine aminotransferase: increased more (High) increased more.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications or treatment information was provided.  On 13Jan2021 had blood work with elevated ALT. On 28Jan2021 same blood work was repeated and ALT increased more.
joint pain; Nausea; Massive headaches; Bouts of chronic and sudden diarrhea; Chronic outbreaks of cluster cold sores more severe and frequent than at any other time of my life; 11Jun2021=Dose 1, 11Jun2021= Dose 2; This is a spontaneous report from a contactable consumer (patient). A 60-years-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number: EW0179), via an unspecified route of administration, administered in right arm on 11Jun2021 as dose 1, single; and received second dose of BNT162B2 (Lot Number: EW0177) via an unspecified route of administration, administered  in right arm on 11Jun2021 as dose 1, single; both (at the age of 60-years-old) for covid-19 immunization at pharmacy or drug Store. Medical history included thyroidectomy, stomach ulcer, cold sores on occasion; all from an unknown date and unknown if ongoing. Concomitant medications  in two weeks included omeprazole magnesium (PRILOSEC), levothyroxine, celecoxib (CELEXA); all taken for an unspecified indication, start and stop date were not reported. The patient had known allergies to Codeine. No other vaccine in four weeks. Patient had no COVID-19 prior vaccination and no COVID-19 tested post vaccination. On 07Jul2021, the patient experienced extreme joint pain throughout body, massive headaches, bouts of chronic and sudden diarrhea, nausea, chronic outbreaks of cluster cold sores more severe and frequent than at any other time of patient's life. No treatment received for events. Patient was not recovered from the events at the time of report.  Follow-up attempts are completed. No further information is expected.
Patient is having chronic worsening pain at injection site over 2 months time after the injection.
PATIENT WAS PRESENTED WITH A RED, HOT RASH ON HIS ARM AT INJECTION SITE WITH A WHITE STREAK RUNNING TOWARD THE ARM PIT.
Presented to ED w/AMS, COVID-19 infection; admitted for COVID-19, sepsis, hypoxia & UTI; tx w/ antibiotics, steroids, zinc; required high-flow oxygen support weaned to RA; pt discharged back to hospital.
This case was reported by a physician via sales rep and described the occurrence of vesicular rash in a female patient who received SHINGRIX for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, 2 days after receiving SHINGRIX, the patient experienced vesicular rash. On an unknown date, the outcome of the vesicular rash was unknown.  It was unknown if the reporter considered the vesicular rash to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The physician stated that she had the patient whom presented with a severe rash 2 to 3 days after receiving a dose of SHINGRIX. The patient experienced rash looked similar to shingles. The patient received the vaccine at local pharmacy and neither could be attributed to anything else. The reporter did not agree to contact for follow up. This case has been linked with case US2018GSK157609, reported by the same reporter.
A couple minutes after injection I felt flush over my chest area. It lasted about 30 seconds then my heart started racing. My iwatch heartrate notified me that my heart rate was 162. This lasted for about 7 minutes. My throat felt a little scratchy but not to where I had anaphylaxis reaction to seafood.
pt recv vax & exp severe pain swelling @ inj site which was reported @ f/u visits;condition resolved in all cases;no further details were provided;
Rash like a sunburn up neck and lower face Body aches Metallic taste in back of throat Fatigue  Joint swelling with redness
Flashes (feeling like muscle tensing but muscles aren?t actually tensed, disorientation, pressure on brain) immediately after both Pfizer doses. Heart palpitations 2 weeks after 2nd dose - diagnosed as iron deficiency. Started taking multivitamin/mineral pills with iron and had horrible reaction (felt like it was hard to breath, extreme fatigue and couldn?t even sit up, extreme nausea) went to ER and blood/ekg/chest X-ray all normal. Let go and during the night had blood rushing, neck swelling, flicking lights when eyes closed. Tried 2 different iron pills, same reaction. Went to Er again and all tests negative. Trying to supplement iron through food (week 4-now). In beginning, week 4 - not getting enough iron from food and constantly feeling short of breath and blood rushing (felt like a lot of blood was being pumped at a time even though pulse was normal). Found iron fortified cereal and it helped shortness of breath, but re-triggered flashes. Flashes getting worse in intensity, length, and frequency. Exertion also shortness of breath and not oxygenating properly walking fat and doing anything more exertional.
Reported that patient had lots of pain the right arm after 2nd does...second does was give on 06/04 and the following day there was pain ..Patient went to the ER and was prescribe 3 medicines but the medication is unknown
right hand which include a mottled appearance on the middle of her hand down to the pads of her fingers; a little rash; and the tips of her fingers feel a bit "prickly like if your hand was really cold and then you put it in hot water".; slight dizziness; This is a spontaneous report from a contactable consumer or other non health care professional. A 67-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration, administered in Left arm on 04Mar2021 as 1st dose, single dose for COVID-19 immunization. Medical history included arthritis, high blood pressure, oral surgery from 01Mar2021 to an unknown date , car accident in mid-February. Concomitant medications included atenolol, motrin taken for pain and oral surgery, tylenol w/codeine, amoxicillin , medrol dosepak taken for accident. The patient experienced right hand which include a mottled appearance on the middle of her hand down to the pads of her fingers ,a little rash and slight dizziness on an unspecified date. The events were assessed as non-serious. On 12Feb2021 we were in a bad accident and ordered Medrol . The patient take a daily vitamin.Caller states she had oral surgery earlier this week and is taking amoxicillin. Could this interact with the vaccine. The outcome of the events was reported as unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
No adverse events to report. Pt received the H1N1 mist on 11/9/09 & then received the H1N1 vaccine on 11/11/09 at Hospital per signed parental consent form.
Severe fever chills muscle aches tiredness and large lump on shoulder were vaccine was given . I slept from 4PM-7:55 AM  today  day three counting day given of vaccine I had  black stool with small amount of blood  and muscles feel sore. Took OTC  Tylenol and ibuprofen to mitigate the chills and fever and will  call  my doctor if the blood in stool symptoms  continue.  I?m mostly recovered  I HAVE NOT HAD TO SEE MY DOCTOR YET I talked with a doctor I know. He said will call them on Monday if the blood in stool continues.
Starting roughly 6 hours after vaccine, he was lethargic, had a low-grade fever of 99.8, had migraines and vomited twice.  The fact sheet I was given covered these symptoms, and the nurse stated they were normal when I called in.
Bleeding after injection; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE HAEMORRHAGE (Bleeding after injection) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A, 028L20A) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INJECTION SITE HAEMORRHAGE (Bleeding after injection). At the time of the report, INJECTION SITE HAEMORRHAGE (Bleeding after injection) outcome was unknown. Unknown          The patient was worried that he did not receive the full dose. The  liquid coming out was more pink than red, so he thought that part of the vaccine was mixed with the blood. Concomitant medications were not provided. Treatment information was not reported.
BLURRED VISION IN AND OUT; WEAKNESS ALL OVER; PAIN ON BOTH HANDS; BODY IS DRAINED; SUPER BAD HEADACHE; This spontaneous report received from a patient concerned a 52 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 08-JUN-2021 for prophylactic vaccination.  The batch number was not reported and has been requested. No concomitant medications were reported. On 08-JUN-2021, the subject experienced blurred vision in and out. On 08-JUN-2021, the subject experienced weakness all over. On 08-JUN-2021, the subject experienced pain on both hands. On 08-JUN-2021, the subject experienced body is drained. On 08-JUN-2021, the subject experienced super bad headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the super bad headache, blurred vision in and out, weakness all over, body is drained and pain on both hands was not reported. This report was non-serious.
Very sore arm (right for the 2nd Moderna); body aches; fatigue; some night chills
This case was reported by a other health professional and described the occurrence of generalized body aches in a female patient who received FLUARIX QUADRIVALENT. On 22nd September 2014, the patient received FLUARIX QUADRIVALENT .5 ml. On 23rd September 2014, 1 days after receiving FLUARIX QUADRIVALENT, the patient experienced generalized body aches, low grade fever and skin soreness. On 26th September 2014, the outcome of the low grade fever was recovered/resolved. On an unknown date, the outcome of the generalized body aches and skin soreness were not recovered/not resolved. The reporter considered the generalized body aches and low grade fever to be probably related to FLUARIX QUADRIVALENT. The reporter considered the skin soreness to be possibly related to FLUARIX QUADRIVALENT. Additional information received: Patient began with low grade fever, generalized body aches and skin soreness 1 day after receiving FLUARIX QIV. HCP was unsure if symptoms are related to FLUARIX QIV 10 days post vaccination.
Bad swelling; This is a spontaneous report from Pfizer Sponsored Program. A contactable consumer (patient) reported for herself. A female patient of an unspecified age received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Lot Number: not reported), via an unspecified route of administration, administered on an unspecified date as 2ND DOSE, SINGLE for COVID-19 immunization. The patient medical history included Mammogram. The patient concomitant medications were not reported. Historical vaccine included BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Formulation: Solution for injection, Lot Number: not reported), via an unspecified route of administration, administered on an unspecified date as 1ST DOSE, SINGLE for COVID-19 immunization. On an unspecified date the patient experienced bad swelling from second vaccine. Had to reschedule Mammogram. She did not get swelling from first vaccine. She Inquired if that was a common side effect. The outcome of the event was unknown.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Hives on right arm and painful to the touch. Instructed patient to see her doctor, but she said she would use Benadryl for now.
Patient received ZOSTAVAX on 12/23/09. Patient developed shingles on 10/07/2011. Had to be treated with acyclovir.
Systemic: Dizziness / Lightheadness-Medium, Systemic: Visual Changes/Disturbances-Medium, Additional Details: PT FELT LIGHTHEADED & BLURRY VISION LASTED FOR ABOUT 2 MINUTES AND RECOVERED AFTER THAT.  PATIENT WAS MONITORED ADDITIONAL 30 MIN AND FELT NORMAL UPON LEAVING
Patient received a vaccine on 8/18/21 at an offsite clinic. Patient states that she experienced severe pain and limited mobility after receiving the vaccine.
SLIGHT MIGRAINE; RECURRENT SWEATING; ACHES AND PAIN; JAW HURT; FEELS SENSITIVE IN THE SKIN AND THE NECK ON THE RIGHT SIDE OF THE FACE; BLOOD GLUCOSE LEVEL OUT OF WHACK; RECURRENT SHIVERING; WEAKNESS; HEADACHE/RIGHT TEMPLE IS SENSITIVE ALONG WITH THE VEINS ON THE RIGHT SIDE ABOVE THE EYE BROW; This spontaneous report received from a patient concerned a 60 year old male. The patient's height, and weight were not reported. The patient's past medical history included accident, and concurrent conditions included diabetic, arthritis pain, and lesion on his hip, and other pre-existing medical conditions included the patient had no known drug allergies. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 204A21A, expiry: 07-AUG-2021) dose was not reported, administered on 28-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 16-MAY-2021, the subject experienced slight migraine. On 16-MAY-2021, the subject experienced recurrent sweating. On 16-MAY-2021, the subject experienced aches and pain. On 16-MAY-2021, the subject experienced jaw hurt. On 16-MAY-2021, the subject experienced feels sensitive in the skin and the neck on the right side of the face. On 16-MAY-2021, the subject experienced blood glucose level out of whack. On 16-MAY-2021, the subject experienced recurrent shivering. On 16-MAY-2021, the subject experienced weakness. On 16-MAY-2021, the subject experienced headache/right temple is sensitive along with the veins on the right side above the eye brow. Laboratory data included: Blood glucose (NR: not provided) 228 mg/dL. On 09-JUN-2021, Laboratory data included: Hip X-ray (NR: not provided) did not find anything wrong, and Laboratory test (NR: not provided) did not find anything wrong. On 12-JUL-2021, Laboratory data included: Blood glucose (NR: not provided) 179 mg/dL. Laboratory data (dates unspecified) included: Blood glucose (NR: not provided) 115 mg/dL. Treatment medications (dates unspecified) included: cefalexin. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from weakness, headache/right temple is sensitive along with the veins on the right side above the eye brow, recurrent sweating, jaw hurt, aches and pain, recurrent shivering, slight migraine, feels sensitive in the skin and the neck on the right side of the face, and blood glucose level out of whack. This report was non-serious.